Variant report
Variant | esv3323551 |
---|---|
Chromosome Location | chr8:60119947-60147653 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:60126464..60129437-chr8:60135528..60137372,2 | MCF-7 | breast: | |
2 | chr8:60089336..60092263-chr8:60117316..60119998,2 | K562 | blood: | |
3 | chr8:60127615..60128279-chr8:60833868..60834810,2 | MCF-7 | breast: | |
4 | chr8:60126464..60129437-chr8:60135528..60137372,2 | MCF-7 | breast: | |
5 | chr8:60131223..60133472-chr8:60135461..60137451,2 | K562 | blood: | |
6 | chr8:60131223..60133472-chr8:60135461..60137451,2 | K562 | blood: | |
7 | chr8:60127735..60128371-chr8:60214631..60215199,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146910175 | chr8:60120639-60120640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111464321 | chr8:60120644-60120645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141457230 | chr8:60120649-60120650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546631107 | chr8:60120657-60120658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559933620 | chr8:60120658-60120659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183365473 | chr8:60120694-60120695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3110122 | chr8:60120700-60120701 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs572759645 | chr8:60120753-60120754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544942656 | chr8:60120778-60120779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565055739 | chr8:60120840-60120841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571592657 | chr8:60120845-60120846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185956921 | chr8:60120874-60120875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550765396 | chr8:60120893-60120894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139012641 | chr8:60120896-60120897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536391109 | chr8:60120897-60120898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575462993 | chr8:60120907-60120908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112334036 | chr8:60120924-60120925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143034849 | chr8:60120969-60120970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534470190 | chr8:60121002-60121003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539010085 | chr8:60121044-60121045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113070118 | chr8:60121059-60121060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558643830 | chr8:60121092-60121093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575628791 | chr8:60121126-60121127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544470748 | chr8:60121170-60121171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547861466 | chr8:60121180-60121181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561071145 | chr8:60121227-60121228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574675050 | chr8:60121281-60121282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544088230 | chr8:60121340-60121341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539998425 | chr8:60121395-60121396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562098236 | chr8:60121702-60121703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570273838 | chr8:60121729-60121730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529839067 | chr8:60121803-60121804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs3122662 | chr8:60121820-60121821 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs4504624 | chr8:60121834-60121835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115661043 | chr8:60121905-60121906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567568927 | chr8:60121955-60121956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370987475 | chr8:60121980-60121981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530294407 | chr8:60122029-60122030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546816280 | chr8:60122062-60122063 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148125556 | chr8:60122069-60122070 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190723458 | chr8:60122103-60122104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs76737746 | chr8:60122147-60122148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74953444 | chr8:60122192-60122193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375511274 | chr8:60122216-60122217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559755050 | chr8:60122217-60122218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370105229 | chr8:60122220-60122221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528475832 | chr8:60122248-60122249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374142427 | chr8:60122283-60122284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182965850 | chr8:60122300-60122301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554898655 | chr8:60122311-60122312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:60120600-60121400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr8:60121600-60122000 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
3 | chr8:60121600-60125000 | Enhancers | Dnd41 | blood |
4 | chr8:60122000-60122800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
5 | chr8:60122000-60122800 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
6 | chr8:60122200-60122800 | Enhancers | GM12878-XiMat | blood |
7 | chr8:60122800-60123000 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
8 | chr8:60123000-60124000 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
9 | chr8:60124000-60124200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
10 | chr8:60128200-60130000 | Enhancers | Dnd41 | blood |
11 | chr8:60130000-60131400 | Weak transcription | Dnd41 | blood |
12 | chr8:60131400-60132200 | Enhancers | Dnd41 | blood |
13 | chr8:60132200-60133200 | ZNF genes & repeats | Dnd41 | blood |
14 | chr8:60132200-60142400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr8:60135400-60135600 | Flanking Bivalent TSS/Enh | Rectal Mucosa Donor 29 | rectum |
16 | chr8:60135400-60136600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
17 | chr8:60135600-60135800 | Bivalent Enhancer | Rectal Mucosa Donor 29 | rectum |
18 | chr8:60135800-60136000 | Flanking Bivalent TSS/Enh | Rectal Mucosa Donor 29 | rectum |
19 | chr8:60136000-60136200 | Bivalent Enhancer | Rectal Mucosa Donor 29 | rectum |
20 | chr8:60136200-60136400 | Flanking Bivalent TSS/Enh | Rectal Mucosa Donor 29 | rectum |
21 | chr8:60139600-60140200 | Enhancers | HUVEC | blood vessel |
22 | chr8:60146200-60146600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
23 | chr8:60147200-60147800 | Enhancers | Fetal Heart | heart |